Ordinary Rebalance | Solactive Global Healthcare Exposure Index | Effective Date 10th May 2023
In the ordinary rebalance, the following index composition will be implemented effective open 10.05.2023:
ABBVIE INC |
AGC INC |
ALFRESA HOLDINGS CORP ORD |
AMGEN INC |
ASAHI KASEI CORP |
ASTELLAS PHARMA INC |
BRISTOL-MYERS SQUIBB CO |
CANON INC |
CVS HEALTH CORP |
GILEAD SCIENCES INC |
GSK PLC |
JOHNSON & JOHNSON |
MEIJI HOLDINGS CO LTD |
MERCK & CO. INC. |
NISSAN CHEMICAL CORP |
NITTO DENKO CORP |
NOVARTIS AG |
PEARSON PLC |
PFIZER INC |
RECKITT BENCKISER GROUP PLC |
ROCHE HOLDING AG |
SANOFI SA |
SANTEN PHARMACEUTICAL CO LTD ORD |
SBI HOLDINGS INC ORD |
SEKISUI CHEMICAL CO LTD ORD |
SOMPO HOLDINGS INC |
STOCKLAND |
SUMITOMO CHEMICAL CO LTD |
TAKEDA PHARMACEUTICAL |
TOSOH CORP |